Celldex Therapeutics - CLDX - close: 24.91 change: +1.01

Stop Loss: 22.90
Target(s): 29.00
Current Gain/Loss: unopened

Entry on September -- at $--.--
Listed on September 16, 2013
Time Frame: 6 to 8 weeks
Average Daily Volume = 1.5 million
New Positions: Yes, see below

Company Description

Why We Like It:
CLDX is a biotech stock. It looks like shares have seen a rebirth given its significant rally from its 2011 lows near $2.50 a share. It seems investors have high hopes for CLDX's current pipeline of drugs in development.

Technically CLDX broke out past resistance near $22 in mid August. The stock seems to have formed a new trend of higher lows and higher highs. Currently CLDX is poised to breakout past round-number resistance at the $25.00 level.

I am suggesting a trigger to open small bullish positions at $25.15. If triggered our target is $29.00 (if you're playing the options I would use a lower target).

NOTE: Traders need to be aware that biotech stocks can be a higher-risk trade. You never know when an unexpected headline about some clinical trial or FDA approval process could send the stock plunging or soaring. I am suggesting investors keep their position size small to limit risk.

Trigger @ 25.15 *small positions*

Suggested Position: buy CLDX stock @ (trigger)

- (or for more adventurous traders, try this option) -

Buy the Oct $25 call (CLDX1319j25) current ask $1.95

Annotated chart: